SCHEMBL7204594

SCHEMBL7204594

CN(C)C(=O)[C@H](Cc1ccccc1)NC(=O)C1OC1C(=O)Nc1ccc(C(N)C(=O)OC(C)(C)C)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MMP9 P14780 2/20 0.41
MMP8 P22894 2/20 0.41
MMP14 P50281 1/20 0.41
CYP3A4 P08684 1/20 0.39
CYP2C8 P10632 1/20 0.39
CYP2C9 P11712 1/20 0.39
NPR3 P17342 1/20 0.39
CYP2C19 P33261 1/20 0.39
MAPT P10636 4/20 0.39
NPSR1 Q6W5P4 2/20 0.39
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
TDP1 Q9NUW8 3/20 0.39
KDM4E B2RXH2 2/20 0.39
CAPN1 P07384 2/20 0.39
LTA4H P09960 1/20 0.38
USP30 Q70CQ3 3/20 0.38
MLYCD O95822 1/20 0.37
ITGA4 P13612 1/20 0.37
ITGB7 P26010 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7209764 0.91 MAPT (0.40) MMP9MMP8MMP14MAPTNPSR1
SCHEMBL7202877 0.86 MMP9 (0.41) MMP9MMP8MMP14MAPTTDP1
SCHEMBL7207457 0.86 MMP9 (0.44) MMP9MMP8MMP14MEN1KMT2A
SCHEMBL7204787 0.86 L3MBTL1 (0.43) MAPTTDP1KDM4ECAPN1POLB
SCHEMBL7203208 0.86 CTSS (0.42) MMP9MAPTKMT2ATDP1KDM4E
SCHEMBL7204598 0.84 MAPT (0.51) MMP9MMP8MMP14MAPTNPSR1
SCHEMBL7205316 0.83 MMP9 (0.55) MMP9MMP8MMP14MEN1KMT2A
SCHEMBL7205323 0.83 MMP9 (0.55) MMP9MMP8MMP14MEN1KMT2A
SCHEMBL7203445 0.82 MMP9 (0.48) MMP9MMP8MMP14MAPTMEN1
SCHEMBL7203452 0.82 MMP9 (0.48) MMP9MMP8MMP14MAPTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0921122-B1 EPOXYSUCCINAMIDE DERIVATIVES OR SALTS THEREOF TAIHO PHARMACEUTICAL CO LTD (JP) 2003-05-21 EP disclosed
US-6110967-A USEFUL AS AGENTS FOR PREVENTING AND TREATING METABOLIC OSTEOPATHY SUCH AS OSTEOPOROSIS, HYPERCALCEMIA AND BONE METASTASIS OF CANCER BECAUSE THEY SPECIFICALLY INHIBITS CATHEPSIN L AND ITS FAMILY ENZYMES TO INHIBIT BONE RESORPTION TAIHO PHARMACEUTICALS CO., LTD. (JP) 2000-08-29 US disclosed
EP-0921122-A1 NOVEL EPOXYSUCCINAMIDE DERIVATIVES OR SALTS THEREOF TAIHO PHARMACEUTICAL COMPANY, LIMITED (JP) 1999-06-09 EP disclosed